Who owns Spero Therapeutics Inc?

Tip: Access positions for across all investors

Analyze quarterly positions in Spero Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Spero Therapeutics stock

Who bought or sold Spero Therapeutics Inc this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Pfizer 2.4M $5.5M 0% Mar 2026
 View chart
Vanguard Group 2.1M $4.9M 5% Dec 2025
 View chart
Vanguard Capital Management 1.8M $4.2M 100% Mar 2026
 View chart
Renaissance Technologies 1.3M $3.0M -12% Dec 2025
 View chart
Alphabet 890k $2.1M 0% Mar 2026
 View chart
Two Sigma Investments 886k $2.1M 138% Mar 2026
 View chart
Geode Capital Management 520k $1.2M -2% Mar 2026
 View chart
BlackRock 433k $1.0M 0% Mar 2026
 View chart
Citadel Advisors 426k $996k -10% Mar 2026
 View chart
Frigate Ventures 422k $987k -32% Mar 2026
 View chart
Susquehanna International 294k $684k 2594% Dec 2025
 View chart
GSA Capital Partners 278k $651k 56% Mar 2026
 View chart
Vanguard Fiduciary Trust 264k $618k 100% Mar 2026
 View chart
State Street Corporation 210k $490k 10% Dec 2025
 View chart
Ionic Capital Management 196k $459k 0% Mar 2026
 View chart
Squarepoint Ops 194k $455k 63% Mar 2026
 View chart
Jane Street 183k $427k -7% Mar 2026
 View chart
Intrepid Family Office 165k $385k 50% Dec 2025
 View chart
Northern Trust 121k $282k -7% Dec 2025
 View chart
Bridgeway Capital Management 115k $268k 0% Dec 2025
 View chart
Shay Capital 70k $165k 100% Mar 2026
 View chart
Point72 Asset Management 60k $140k 37% Mar 2026
 View chart
Invesco 45k $106k 84% Mar 2026
 View chart
OMERS Administration Corporation 39k $92k -70% Mar 2026
 View chart
Quadrature Capital 38k $88k 100% Dec 2025
 View chart
Simplex Trading 36k $83k 368% Dec 2025
 View chart
Capital Asset Advisory Services 33k $92k 0% Mar 2026
 View chart
Three Seasons Wealth 30k $70k 0% Mar 2026
 View chart
Dimensional Fund Advisors 30k $70k 0% Mar 2026
 View chart
Charles Schwab Investment Management 29k $67k 0% Dec 2025
 View chart
Vanguard Global Advisers 25k $60k 100% Mar 2026
 View chart
Schonfeld Strategic Advisors 20k $48k 100% Mar 2026
 View chart
Citigroup 19k $45k 100% Mar 2026
 View chart
Assenagon Asset Management 19k $44k 0% Mar 2026
 View chart
Torrey Growth & Income Advisors 17k $38k 100% Mar 2026
 View chart
Occudo Quantitative Strategies 16k $41k 100% Mar 2026
 View chart
XTX Topco 15k $35k -55% Dec 2025
 View chart
Tower Research Capital 7.2k $17k 100% Dec 2025
 View chart
Jones Financial Companies, L.L 6.5k $15k 100% Dec 2025
 View chart
FNY Investment Advisers 5.3k $12k 0% Mar 2026
 View chart
Morgan Stanley 4.6k $11k 1354% Mar 2026
 View chart
UBS Group 3.0k $7.0k -97% Mar 2026
 View chart
Advisor Group Holdings 290.00 $675.004000 0% Dec 2025
 View chart
Wells Fargo & Company 200.00 $468.000000 0% Mar 2026
 View chart
Us Bancorp 151.00 $351.996100 0% Dec 2025
 View chart
Bnp Paribas Arbitrage, Snc 40.00 $94.000000 0% Mar 2026
 View chart
SageView Advisory Group 17.00 $39.999300 100% Dec 2025
 View chart
Farther Finance Advisors 10.00 $25.000000 0% Mar 2026
 View chart
SBI Securities 9.00 $20.999700 0% Mar 2026
 View chart
Caitong International Asset Management 3.00 $6.999900 100% Mar 2026
 View chart

Who sold out of Spero Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Eudaimonia Asset Management Dec 2025 218k $508k
Two Sigma Advisers Dec 2025 217k $505k
Arrowstreet Capital, Limited Partnership Sep 2025 151k $283k
Sei Investments Dec 2025 132k $0
ADAR1 Capital Management Dec 2025 114k $265k
None Dec 2025 60k $141k
American Century Companies Sep 2025 40k $76k
Axxcess Wealth Management Dec 2025 33k $76k
Millennium Management Dec 2025 24k $56k
Yale Capital Corp. Dec 2025 10k $23k
Cullen Frost Bankers Dec 2025 3.0k $7.0k
FMR Sep 2025 550.00 $1.0k
Jpmorgan Chase & Co Sep 2025 236.00 $444.010400
Rockefeller Capital Management Dec 2025 200.00 $466.000000